Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKGP.L Regulatory News (KGP)

  • There is currently no data for KGP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

13 Nov 2017 07:00

RNS Number : 2382W
Kingspan Group PLC
13 November 2017
 

Kingspan Group Plc

Trading Update

 

13 November 2017

 

Kingspan Group plc, the global leader in high performance insulation and building envelope solutions, today issues a Trading Update, with trading information for the period to 30 September 2017.

Sales in the nine month period to 30 September were €2.69bn, up 19% on the same period in the prior year (+21% pre currency). Sales in the third quarter were up 17% (+20% pre currency). Underlying sales, pre currency and acquisitions, were up 11% in the year to date and were up 13% in the third quarter.

Insulated Panel sales in the first nine months increased by 16% (+18% pre currency), and increased by 13% (+15% pre currency) in the third quarter. Underlying sales were 12% ahead both year to date and in the third quarter, owing significantly to the pass-through of input related inflation. Mainland European sales were solid in most markets and notably positive in France. In the UK we have experienced a sense of near-term indecision around order placement, however our future activity tracker remains modestly ahead of prior year. North America sales were solid overall, and in Latin America we have experienced very encouraging activity since taking a position there in recent months.

Insulation Board sales in the first nine months were up 10% (+13% pre currency) and were up by 16% in quarter three (+19% pre currency). Underlying sales growth was 13% year to date and 19% in the third quarter. Sales growth year on year reflected strong price growth necessitated by raw material inflation. In addition Kooltherm® volume continued to outgrow our other insulation materials, and was particularly positive in the UK, Ireland, Western Europe and the Nordics. The North America and Australasia markets are still in a developmental phase for Kingspan as we are still in the early days of generating demand for high performance insulation in these markets.

 

Light & Air sales both year to date and in the third quarter are strongly ahead reflecting year on year acquisition activity. Underlying sales year to date grew by 4% and by 7% in the third quarter. As we exit 2017 the annualised sales of this division will be in the region of €220m.

Environmental sales in the first nine months were up 12% (+17% pre currency) and were up 11% (+14% pre currency) in the third quarter. A particular highlight was the ongoing growth in rainwater harvesting in Australia. UK and Europe sales were solid overall, and margins continue to progress upwards.

Access Floors sales in the first nine months increased by 2% (+5% pre currency) and were up 4% (+9% pre currency) in the third quarter. UK office activity is softening, as expected, with the US office market remaining relatively flat. Datacentre activity across the division was encouraging as was the continued growth in sales of our broader product portfolio into that segment.

 

Net debt at the end of September 2016 was €479.8m. Net debt at year end is forecast to be in the region of €400m.

 

On the back of significant input inflation in the third quarter, and our associated price inflation, we anticipate this trend to remain through the fourth quarter albeit less pronounced as chemical cost increases reach their peak. In general our end markets are relatively stable, notwithstanding some recent evidence of a slowdown in UK commercial and industrial activity. Separately, the Group's development pipeline is encouraging.

 

Assuming current exchange rates prevail and conscious that much of the seasonally variable fourth quarter remains, we expect to deliver full year trading profit growth of approximately 10% or c. €375m.

 

For further information contact:

 

Gene Murtagh, Chief Executive Officer Tel: +353 (0) 42 9698000

 

Geoff Doherty, Chief Financial Officer Tel: +353 (0) 42 9698000

 

Douglas Keatinge, Murray Consultants Tel: +353 (0) 1 4980300

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTOKKDBOBDDADD
Date   Source Headline
1st Nov 20193:33 pmRNSTotal Voting Rights
1st Oct 20193:31 pmRNSTotal Voting Rights
24th Sep 20195:38 pmRNSHolding(s) in Company
17th Sep 20195:41 pmRNSHolding(s) in Company
2nd Sep 20191:04 pmRNSTotal Voting Rights
23rd Aug 20197:00 amRNSHalf-year Report
23rd Aug 20197:00 amRNSEuronext Dublin Market Notice
22nd Aug 20193:13 pmRNSHolding(s) in Company
19th Aug 20193:00 pmRNSBlock Listing Application
8th Aug 20199:22 amRNSHolding(s) in Company
11th Jul 20193:38 pmRNSHolding(s) in Company
1st Jul 20195:35 pmRNSBlock listing Interim Review
1st Jul 20193:14 pmRNSTotal Voting Rights
1st Jul 201910:41 amRNSCorporate Broker Appointment
19th Jun 20193:57 pmRNSDirector/PDMR Shareholding
18th Jun 20195:25 pmRNSDirector/PDMR Shareholding
5th Jun 20194:52 pmRNSDirector/PDMR Shareholding
4th Jun 20191:04 pmRNSTotal Voting Rights
4th Jun 201910:33 amRNSHolding(s) in Company
21st May 201910:30 amRNSDirector/PDMR Shareholding
20th May 20197:00 amRNSHolding(s) in Company - REPLACEMENT
17th May 20194:20 pmRNSDirector/PDMR Shareholding
17th May 20194:16 pmRNSHolding(s) in Company
9th May 20195:46 pmRNSDirector/PDMR Shareholding
9th May 20195:46 pmRNSDirector Declaration
7th May 20195:07 pmRNSResult of AGM
7th May 20193:42 pmRNSDirector/PDMR Shareholding
3rd May 20197:00 amRNSAGM Statement
1st May 201910:37 amRNSTotal Voting Rights
26th Apr 20197:15 amRNSStatement re Recticel NV/SA
16th Apr 201910:15 amRNSStatement re Recticel NV/SA
1st Apr 20195:13 pmRNSTotal Voting Rights
27th Mar 20194:40 pmRNSHolding(s) in Company
27th Mar 20192:39 pmRNSDirector/PDMR Shareholding
19th Mar 201910:27 amRNSHolding(s) in Company
14th Mar 201912:36 pmRNSDirector/PDMR Shareholding
13th Mar 201910:01 amRNSChange of Adviser
5th Mar 201912:30 pmRNSAnnual Financial Report
4th Mar 20193:52 pmRNSHolding(s) in Company
1st Mar 20194:16 pmRNSTotal Voting Rights
26th Feb 20199:45 amRNSDirector/PDMR Shareholding
22nd Feb 20197:00 amRNSFinal Results
18th Feb 201911:22 amRNSHolding(s) in Company
14th Feb 20195:43 pmRNSHolding(s) in Company
8th Feb 20193:02 pmRNSHolding(s) in Company
4th Feb 20194:27 pmRNSHolding(s) in Company
23rd Jan 20195:35 pmRNSHolding(s) in Company
11th Jan 201912:51 pmRNSHolding(s) in Company
2nd Jan 201910:30 amRNSBlock listing Interim Review
2nd Jan 201910:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.